Company Filing History:
2 out of 633 
2 out of 2 Years Active: 2021-2025
Title: Sathyamoorthy Bhaskar: Innovator in Therapeutic Delivery Systems
Introduction
Sathyamoorthy Bhaskar is a notable inventor based in Singapore, SG. He has made significant contributions to the field of therapeutic delivery systems, particularly focusing on melanocyte-targeting technologies. With a total of 2 patents, his work is paving the way for advancements in treating hyperpigmentation and related disorders.
Latest Patents
One of his latest patents is titled "Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages." This invention relates to protein nanocages that comprise a melanocyte-targeting moiety and pharmaceutical compositions. These compositions are designed for treating or diagnosing hyperpigmentation disorders or other melanocyte-related disorders. The preferred embodiment of the protein nanocage is composed of the E2 protein of the pyruvate dehydrogenase multi-enzyme complex, which includes a skin-penetrating and cell-permeating SPACE moiety, along with a melanocyte-targeting moiety derived from alpha melanocyte-stimulating hormone.
Career Highlights
Sathyamoorthy has worked with esteemed institutions such as Nanyang Technological University and the National Skin Center Pte Ltd. His experience in these organizations has allowed him to collaborate on innovative projects that enhance therapeutic delivery methods.
Collaborations
He has collaborated with notable coworkers, including Sierin Lim and Steven Thng, contributing to a dynamic research environment that fosters innovation.
Conclusion
Sathyamoorthy Bhaskar's work in developing protein nanocages for targeted therapeutic delivery showcases his commitment to advancing medical science. His inventions hold promise for improving treatment options for patients with melanocyte-related disorders.